y69a2ar.19
C. elegans
Protein-tyrosine-phosphatase
What the model saw
Gene: Y69A2AR.19 Organism: Caenorhabditis elegans Known functions: Protein-tyrosine-phosphatase. protein tyrosine phosphatase activity.
View unredacted entry
Protein-tyrosine-phosphatase. protein tyrosine phosphatase activity.
Solver output
Protein tyrosine phosphatases (PTPs) can either promote or oppose longevity depending on their specific substrates and the signaling context. In C. elegans, the insulin/IGF-1 signaling (IIS) pathway is a major longevity regulator, and PTPs can dephosphorylate key components such as DAF-2 (insulin receptor) or downstream kinases, potentially modulating DAF-16/FOXO activity. However, PTPs also regulate other tyrosine-phosphorylated substrates outside IIS, including MAPK and growth factor pathways. Without knowledge of the specific substrate(s) of Y69A2AR.19, it is impossible to determine whether its phosphatase activity attenuates pro-longevity or pro-aging signals. The annotation is too broad to confidently assign a directional longevity influence.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted "unclear" while the ground truth is "anti_longevity." The model's reasoning about PTPs being ambiguous in longevity contexts is generally sound, but it failed to commit to the correct answer. The model's uncertainty was somewhat reasonable given the limited information provided (only protein tyrosine phosphatase activity was annotated), but it still got the answer wrong. The mechanistic reasoning about IIS/DAF-2/DAF-16 pathways is plausible but not specifically correct for this gene. The model's confidence of 0.38 reflects appropriate uncertainty, but the prediction of "unclear" rather than "anti_longevity" is incorrect.
Raw API responses
solver
{
"reasoning": "Protein tyrosine phosphatases (PTPs) can either promote or oppose longevity depending on their specific substrates and the signaling context. In C. elegans, the insulin/IGF-1 signaling (IIS) pathway is a major longevity regulator, and PTPs can dephosphorylate key components such as DAF-2 (insulin receptor) or downstream kinases, potentially modulating DAF-16/FOXO activity. However, PTPs also regulate other tyrosine-phosphorylated substrates outside IIS, including MAPK and growth factor pathways. Without knowledge of the specific substrate(s) of Y69A2AR.19, it is impossible to determine whether its phosphatase activity attenuates pro-longevity or pro-aging signals. The annotation is too broad to confidently assign a directional longevity influence.",
"confidence": 0.38,
"key_pathways": [
"insulin/IGF-1 signaling (IIS)",
"DAF-2/DAF-16 axis",
"MAPK signaling"
],
"mechanism_class": "deregulated_nutrient_sensing",
"longevity_influence": "unclear"
}advisor
{
"notes": "The model predicted \"unclear\" while the ground truth is \"anti_longevity.\" The model's reasoning about PTPs being ambiguous in longevity contexts is generally sound, but it failed to commit to the correct answer. The model's uncertainty was somewhat reasonable given the limited information provided (only protein tyrosine phosphatase activity was annotated), but it still got the answer wrong. The mechanistic reasoning about IIS/DAF-2/DAF-16 pathways is plausible but not specifically correct for this gene. The model's confidence of 0.38 reflects appropriate uncertainty, but the prediction of \"unclear\" rather than \"anti_longevity\" is incorrect.",
"failure_mode": "appropriately_uncertain",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}